omega-n-methylarginine has been researched along with phenoxybenzamine in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (phenoxybenzamine) | Trials (phenoxybenzamine) | Recent Studies (post-2010) (phenoxybenzamine) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 5,006 | 70 | 95 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | phenoxybenzamine (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 4.9 | |
| Solute carrier family 22 member 1 | Homo sapiens (human) | 2.72 | |
| Solute carrier family 22 member 3 | Homo sapiens (human) | 6.13 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davies, MG; Hagen, PO; Huynh, TT | 1 |
1 other study(ies) available for omega-n-methylarginine and phenoxybenzamine
| Article | Year |
|---|---|
Characterization of dopamine-mediated relaxation in experimental vein bypass grafts.
Topics: Adjuvants, Immunologic; Adrenergic alpha-Antagonists; Animals; Cardiotonic Agents; Cardiovascular Agents; Carotid Artery, Common; Cholera Toxin; Dopamine; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Graft Occlusion, Vascular; GTP-Binding Proteins; Hyperplasia; Indomethacin; Jugular Veins; Male; Nitric Oxide; omega-N-Methylarginine; Phenoxybenzamine; Prostaglandins; Rabbits; Receptors, Adrenergic, alpha; Receptors, Dopamine; Tunica Intima; Vasodilation | 2000 |